We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
National Fuel Gas
NFG
$7.65B
| $11.1M | ﹤0.01% |
179,628
-5,764
| -3% | -$397K |
|
1402
Asbury Automotive
ABG
$3.85B
| $11M | ﹤0.01% |
73,111
-1,185
| -2% | -$202K |
|
|
BERY
1403
DELISTED
Berry Global Group, Inc.
BERY
| $11M | ﹤0.01% |
257,853
-19,600
| -7% | -$985K |
|
1404
Mine Safety
MSA
$7.49B
| $11M | ﹤0.01% |
100,513
-5,396
| -5% | -$664K |
|
|
SI
1405
DELISTED
Silvergate Capital Corporation
SI
| $10.9M | ﹤0.01% |
144,984
-3,121
| -2% | -$266K |
|
1406
Vir Biotechnology
VIR
$1.49B
| $10.9M | ﹤0.01% |
566,381
-99,846
| -15% | -$2.54M |
|
1407
Artisan Partners
APAM
$3.02B
| $10.9M | ﹤0.01% |
404,161
-98,209
| -20% | -$3.45M |
|
1408
United Parks & Resorts
PRKS
$2.12B
| $10.9M | ﹤0.01% |
238,871
+12,391
| +5% | +$617K |
|
|
SGI
1409
Somnigroup International
SGI
$13.7B
| $10.9M | ﹤0.01% |
449,644
-20,811
| -4% | -$539K |
|
1410
First Hawaiian
FHB
$3.35B
| $10.8M | ﹤0.01% |
439,877
+46,823
| +12% | +$1.18M |
|
1411
Golar LNG
GLNG
$5.13B
| $10.8M | ﹤0.01% |
434,450
-400,917
| -48% | -$10M |
|
1412
StepStone Group
STEP
$3.82B
| $10.8M | ﹤0.01% |
440,284
-137,930
| -24% | -$3.76M |
|
1413
Denali Therapeutics
DNLI
$3.97B
| $10.8M | ﹤0.01% |
351,459
-8,699
| -2% | -$283K |
|
1414
Simply Good Foods
SMPL
$982M
| $10.8M | ﹤0.01% |
337,139
-158,183
| -32% | -$5.19M |
|
1415
Karyopharm Therapeutics
KPTI
$48M
| $10.8M | ﹤0.01% |
131,403
+5,044
| +4% | +$377K |
|
1416
First Busey Corp
BUSE
$2.56B
| $10.7M | ﹤0.01% |
488,523
+100,091
| +26% | +$2.37M |
|
1417
GDS Holdings
GDS
$6.41B
| $10.7M | ﹤0.01% |
606,452
+26,357
| +5% | +$692K |
|
1418
Asana
ASAN
$2.13B
| $10.7M | ﹤0.01% |
481,739
+40,954
| +9% | +$879K |
|
|
ETRN
1419
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $10.7M | ﹤0.01% |
1,429,116
+2,342
| +0.2% | +$19.6K |
|
1420
Vanda Pharmaceuticals
VNDA
$302M
| $10.7M | ﹤0.01% |
1,078,891
+91,106
| +9% | +$962K |
|
1421
Maximus
MMS
$3.1B
| $10.7M | ﹤0.01% |
184,141
+3,793
| +2% | +$236K |
|
1422
Armstrong World Industries
AWI
$7.84B
| $10.7M | ﹤0.01% |
134,436
-5,606
| -4% | -$474K |
|
1423
PTC Therapeutics
PTCT
$6.12B
| $10.6M | ﹤0.01% |
211,370
-2,662
| -1% | -$130K |
|
1424
Stewart Information Services
STC
$2.08B
| $10.6M | ﹤0.01% |
242,971
-177
| -0.1% | -$9.04K |
|
1425
CareTrust REIT
CTRE
$9.74B
| $10.6M | ﹤0.01% |
585,417
-177,211
| -23% | -$3.61M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.